Skip to content
Disclosery

EXANE DERIVATIVES: GLD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on GLD, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,935 GLD shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,935 shares
    Change vs previous 13F -7,342 shares

    0.28% of the 13F portfolio, value $494,329.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 10,277 shares
    Change vs previous 13F -2,471 shares

    0.52% of the 13F portfolio, value $1,856,426.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 12,748 shares
    Change vs previous 13F +2,022 shares

    0.53% of the 13F portfolio, value $2,179,319.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 10,726 shares
    Change vs previous 13F +230 shares

    0.44% of the 13F portfolio, value $1,761,361.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 10,496 shares
    Change vs previous 13F +2,016 shares

    0.42% of the 13F portfolio, value $1,776,093.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 8,480 shares
    Change vs previous 13F -1,321 shares

    0.41% of the 13F portfolio, value $1,356,401.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 9,801 shares
    Change vs previous 13F +3,403 shares

    0.53% of the 13F portfolio, value $1,748,025.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 6,398 shares
    Change vs previous 13F not available

    0.37% of the 13F portfolio, value $1,133,151.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).